Development, implementation, and evaluation of a clinical decision support tool to improve naloxone coprescription within Military Health System pharmacies. (14th May 2021)

• Record Type: Journal Article
• Authors: Rittel, Alexander G; Highland, Krista B; Maneval, Mark S; Bockhorst, Archie D; Moreno, Agustin; Sim, Alan; Easter, Peter S; Nichols, Chris E; Costantino, Ryan C
• Is Part Of: American journal of health-system pharmacy. Volume 79:Number 1(2022)
• Page Start: e58
• Page End: e64
• Publication Date: 2021-05-14
• Subjects: clinical decision support -- military -- naloxone -- opioids -- overdose -- pharmacy; Hospital pharmacies -- United States -- Periodicals; 615.1
• DOI: 10.1093/ajhp/zxab206
• Languages: English
• ISSNs: 1079-2082

Abstract

Abstract: Purpose: To describe the development, implementation, and evaluation of a pharmacy clinical decision support tool designed to increase naloxone coprescription among people at risk for opioid overdose in a large healthcare system. Summary: The Military Health System Opioid Registry and underlying presentation layer were used to develop a clinical decision support capability to improve naloxone coprescription at the pharmacy point of care. Pharmacy personnel use a patient identification card barcode scanner or manually enter a patient's identification number to quickly visualize information on a patient's risk for opioid overdose and medical history related to pain and, when appropriate, receive a recommendation to coprescribe naloxone. The tool was made available to military treatment facility pharmacy locations. An interactive dashboard was developed to support monitoring, utilization, and impact on naloxone coprescription to patients at risk for opioid overdose. Conclusion: Initial implementation of the naloxone tool was slow from a lack of end-user awareness. Efforts to increase utilization were, in part, successful owing to a number of enterprise-wide educational initiatives. In early 2020, the naloxone tool was used in 15% of all opioid prescriptions dispensed at a military pharmacy. Data indicate that the frequency of naloxone coprescription to patients at risk for opioid overdose was significantly higher when the naloxone tool was used than when the tool was not used.